Related Experiment Video

Updated: Jul 7, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

[Continuous intraspinal ceftazidime administration in a case for treatment of purulent meningitis]

Jia Yin1, Tian-ming Lü, Xiao-jia Liu

  • 1Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. yinjiajia@263.net

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|February 6, 2008
PubMed
Abstract

Insights

Continuous intraspinal ceftazidime effectively treated purulent meningitis caused by Achromobacter infection when intravenous methods failed. This novel approach offers a safe and viable alternative for severe meningitis cases.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Pharmacology

Background:

  • Purulent meningitis requires effective antibiotic treatment.
  • Achromobacter infections can be challenging to treat with standard intravenous antibiotics.
  • Intraspinal antibiotic delivery is an alternative route for central nervous system infections.

Observation:

  • A patient with Achromobacter meningitis refractory to intravenous ceftazidime was treated.
  • Continuous intraspinal ceftazidime was administered via a cisterna magna catheter.
  • Intrathecal ceftazidime was previously attempted but poorly tolerated.

Findings:

  • Continuous intraspinal ceftazidime resulted in significant symptom improvement.
  • The patient achieved a full recovery with no relapse after 3 months.
  • This method was found to be effective and safe in this case.

Implications:

  • Continuous intraspinal ceftazidime may be a feasible treatment for resistant bacterial meningitis.
  • This administration route could be beneficial for central nervous system infections.
  • Further research is warranted to explore intraspinal antibiotic delivery for meningitis.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...